Business
MustGrow Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT Program
Approval from Health Canada's Pest Management Regulatory Agency (PMRA) to commence large-scale fa...

About this update from Mustgrow Biologics Corp.
[{"type":"text","content":"MustGrow Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT ProgramApproval from Health Canada's Pest Management Regulatory Agency (PMRA) to commence large-scale farmer trials.Program to focus on MustGrow's TerraMG™ mustard-derived soil biopesticide technology for use in Canadian canola and pulse crop markets.NexusBioAg's 2024 BioAdvantage Trials (BAT) Program to evaluate large-scale efficacy and commercial value potential.MustGrow and NexusBioAg are committed to launching innovative, sustainable, and regenerative agriculture products.Saskatoon, Saskatchewan--(Newsfile Corp. - November 7, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the \"Company\" or \"MustGrow\") is pleased to announce the approval of Health Canada's Pest Management Regulatory Agency (\"PMRA\") to commence large-scale field trials via NexusBioAg's 2024 BioAdvantage Trials Program (\"BAT Program\"). NexusBioAg, is a division of Univar Solutions, providing an expanded portfolio of crop nutrition solutions, including industry-leading inoculants, micronutrients, nitrogen stabilizers, and foliar products. NexusBioAg is partnered with MustGrow to provide TerraMGTM to Canadian farmers, upon PMRA registraion, as a preplant soil treatment for diseases affecting canola and pulse crops. NexusBioAg's BAT Program is recognized as an industry leading field trialing program with an established process to gather data from large field scale trials across Canada. Since it's inception, NexusBioAg continues to expand the BAT Program footprint and engage with collaborators to evaluate products in the NexusBioAg pipeline. Through the BAT Program, NexusBioAg validates product efficacy and establishes the product value and opportunity. To learn more about the BAT Program, visit www.nexusbioag.com/bioadvantage-trials.The BAT Program will focus on MustGrow's TerraMGTM mustard-derived soil biopesticide technology for use in Canadian canola and pulse crop markets. The addition of this plant-based technology to the BAT Program further diversifies and expands NexusBioAg's extensive portfolio of inoculants, micronutrients, nitrogen stabilizers and foliars for the Canadian agricultural market.\"There has been a significant amount of grower interest in MustGrow's TerraMGTM and there is excitement to evaluate TerraMGTM in real farm...